United Therapeutics Corporation (UTHR) Insider Trading

Total insider buys:
  • $999,400.80
Total insider sells:
  • $709,937,905.41
Most recent insider trade:
  • July 10, 2024
Most active insider trader:
  • Martine A Rothblatt
Trader NameDateTitleAmountPriceTypeTotal Value
July 10, 2024CEO3,600$326.35Sell$1,174,860.00
July 8, 2024CEO3,600$317.05Sell$1,141,380.00
July 5, 2024CEO3,600$313.25Sell$1,127,700.00
July 3, 2024CEO3,600$312.48Sell$1,124,928.00
July 1, 2024CEO3,600$320.45Sell$1,153,620.00
June 27, 2024CEO3,600$316.62Sell$1,139,832.00
June 25, 2024Director266$318.58Sell$84,742.28
June 24, 2024CEO3,600$315.97Sell$1,137,492.00
June 21, 2024CEO3,600$313.91Sell$1,130,076.00
June 14, 2024CEO3,600$287.22Sell$1,033,992.00
June 13, 2024Director2,000$281.53Sell$563,060.00
June 12, 2024CEO3,600$281.19Sell$1,012,284.00
June 10, 2024CEO3,600$273.95Sell$986,220.00
June 7, 2024CEO3,600$277.13Sell$997,668.00
May 31, 2024CEO3,600$272.48Sell$980,928.00
May 28, 2024Director3,600$269.06Sell$968,616.00
May 23, 2024Director3,600$275.78Sell$992,808.00
May 21, 2024Director1,468$275.85Sell$404,947.80
May 16, 2024Director3,600$272.37Sell$980,532.00
May 14, 2024Director1,310$264.35Sell$346,298.50
May 13, 2024CEO3,600$265.48Sell$955,728.00
May 9, 2024CEO3,600$264.22Sell$951,192.00
May 6, 2024CEO3,600$259.70Sell$934,920.00
May 3, 2024Director2,240$259.91Sell$582,198.40
May 2, 2024CEO3,600$258.09Sell$929,124.00
April 30, 2024CEO3,600$235.35Sell$847,260.00
April 26, 2024CEO3,600$235.20Sell$846,720.00
April 24, 2024CEO3,600$238.81Sell$859,716.00
April 22, 2024CEO3,600$236.47Sell$851,292.00
April 18, 2024CEO3,600$237.91Sell$856,476.00
April 16, 2024CEO3,600$232.05Sell$835,380.00
April 12, 2024CEO3,600$235.42Sell$847,512.00
April 10, 2024CEO13,800$237.27Sell$3,274,326.00
April 8, 2024CEO5,060$237.52Sell$1,201,851.20
April 4, 2024CEO15,000$233.27Sell$3,499,050.00
April 4, 2024EVP6,000$232.37Sell$1,394,220.00
March 28, 2024CEO14,125$236.18Sell$3,336,042.50
March 27, 2024Director325$237.80Sell$77,285.00
March 26, 2024CEO15,000$248.33Sell$3,724,950.00
March 22, 2024CEO15,000$237.05Sell$3,555,750.00
March 21, 2024EVP6,000$236.45Sell$1,418,700.00
March 19, 2024CEO15,000$236.59Sell$3,548,850.00
Feb. 23, 2024Director1,680$224.00Sell$376,320.00
Feb. 15, 2024EVP6,000$215.31Sell$1,291,860.00
Feb. 1, 2024EVP6,000$215.01Sell$1,290,060.00
Jan. 18, 2024EVP6,000$218.72Sell$1,312,320.00
Jan. 4, 2024EVP6,000$227.97Sell$1,367,820.00
Dec. 21, 2023EVP6,000$229.27Sell$1,375,620.00
Dec. 19, 2023Director605$244.90Sell$148,164.50
Dec. 12, 2023Director3,000$249.68Sell$749,040.00
First«1 of 17»Last
  • Insiders are both buying and selling United Therapeutics Corporation stock.

  • The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, John Maxim Ferrari, Raymond Dwek, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, Nilda Mesa, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Paul A. Mahon, Ray Kurzweil, Tommy G. Thompson, Louis Sullivan, MAHON PAUL A, DWEK RAYMOND, R Paul Gray, and Judy D. Olian

  • The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 374 trades.

  • Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $360,170,406.62.

  • Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.

  • The most recent insider trade for United Therapeutics Corporation was on July 10, 2024.

  • The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.

  • The single biggest insider sell for United Therapeutics Corporation was from Roger Jeffs with a total value of $6,551,000.00 on Sept. 23, 2014.